Erectile dysfunction. Male erectile dysfunction, unspecified
Conditions
Interventions
Intervention 1: Intervention group 1: Maintenance regimen of tadalafil tablets 5 mg daily for 12 consecutive weeks. Intervention 2: Intervention group 2: Tadalafil 10 mg tablet regimen before sexual a
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: Men aged 40 to 70 years Diagnosis of erectile dysfunction by a urology specialist IIEF-5 score = 21 Having at least two sexual activities per week Not having used PDE5 inhibitor drugs within the 4 weeks prior to study entry Written informed consent to participate in the study Normal serum testosterone level
Exclusion criteria
Exclusion criteria: Allergy to tadalafil Prohibited drug interactions such as nitrates Use of other PDE5 inhibitors within the last 4 weeks Unwillingness to give informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| International Index of Erectile Function 5- items Score Questionnaire Score. Timepoint: At the beginning of the study and after 8 weeks, requested tests are requested after using various doses of tadalafil. Method of measurement: International Index of Erectile Function 5- items Score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammadjavad Nazarpour
Esfahan University of Medical Sciences
Outcome results
None listed